Consensus on the definitions and descriptions of the domains of the OMERACT Core Outcome Set for shared decision making interventions in rheumatology trials

被引：2

作者：

Decary, Simon ^{[1
]}

de Wit, Maarten ^{[2
]}

Naye, Florian ^{[1
]}

Barton, Jennifer L. ^{[3
]}

Fraenkel, Liana ^{[4
]}

Li, Linda C. ^{[5
,6
]}

Brooks, Peter ^{[7
,8
]}

Stacey, Dawn ^{[9
,10
]}

Maxwell, Lara J. ^{[11
,12
]}

Campbell, Willemina ^{[13
]}

Hofstetter, Cathie

Voshaar, Marieke ^{[14
,15
,16
]}

Meara, Alexa ^{[17
]}

Christensen, Robin ^{[18
,19
]}

Boonen, Annelies ^{[20
,21
]}

Suarez-Almazor, Maria E. ^{[22
]}

Meade, Tanya ^{[23
]}

March, Lyn ^{[24
]}

Jull, Janet Elizabeth ^{[25
]}

Alten, Rieke ^{[26
]}

Morgan, Esi M. ^{[27
]}

Hazlewood, Glen Stewart ^{[28
]}

Barber, Claire E. H. ^{[29
]}

Guillemin, Francis ^{[30
]}

El-Miedany, Yasser ^{[31
,32
]}

Mittoo, Shikha ^{[33
]}

Robertson, Tiffany Westrich ^{[34
]}

Bartlett, Susan J. ^{[35
,36
,37
]}

Singh, Jasvinder A. ^{[38
]}

Mannion, Melissa ^{[39
]}

Nasef, Samah Ismail ^{[40
]}

Boel, Anne ^{[41
,42
]}

Adebajo, Adewale ^{[43
]}

Arnaud, Laurent ^{[44
]}

Gill, Tiffany K. ^{[45
]}

Moholt, Ellen ^{[46
]}

Burt, Jennifer ^{[47
]}

Jayatilleke, Arundathi ^{[48
]}

Hmamouchi, Ihsane ^{[49
]}

Berthelsen, Dorthe B. ^{[50
,51
,52
]}

Blanco, Francisco J. ^{[53
]}

Mather, Kate ^{[54
]}

Maharaj, Ajesh ^{[55
]}

Sharma, Saurab ^{[56
,57
]}

Caso, Francesco ^{[58
]}

Beaton, Dorcas ^{[59
]}

Shea, Beverly ^{[60
,61
,62
]}

Fong, Christopher ^{[63
]}

Fernandez, Anthony P. ^{[64
,65
]}

Mackie, Sarah ^{[66
]}

机构：

[1] Univ Sherbrooke, Sch Rehabil,Fac Med & Hlth Sci, Res Ctr,CHUS, CIUSSS EstrieCHUS, Sherbrooke, PQ, Canada

[2] Patient Res Partner, Amsterdam, Netherlands

[3] Oregon Hlth & Sci Univ, VA Portland Hlth Care Syst, Portland, OR USA

[4] Yale Univ, Dept Internal Med, New Haven, CT USA

[5] Univ British Columbia, Dept Phys Therapy, Vancouver, BC, Canada

[6] Arthrit Res Canada, Vancouver, BC, Canada

[7] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Australia

[8] Northern Hlth, Melbourne, Australia

[9] Univ Ottawa, Sch Nursing, Ottawa, ON, Canada

[10] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[11] Univ Ottawa, Ottawa Hosp Res Inst, Ctr Practice Changing Res, Ottawa, ON, Canada

[12] Univ Ottawa, Fac Med, Ottawa, ON, Canada

[13] Toronto Western Hosp, Univ Hlth Network, Patient Res Partner, Toronto, ON, Canada

[14] Sint Maartenskliniek, Dept Pharm, Nijmegen, Netherlands

[15] Sint Maartenskliniek, Dept Res Innovat, Nijmegen, Netherlands

[16] Radboud Univ Nijmegen, Dept Pharm, Med Ctr, Nijmegen, Netherlands

[17] Ohio State Univ, Div Rheumatol, Columbus, OH USA

[18] Bispebjerg & Frederiksberg Hosp, Parker Inst, Musculoskeletal Stat Unit, Copenhagen, Denmark

[19] Odense Univ Hosp, Dept Rheumatol, Odense, Denmark

[20] Maastricht Univ, Div Rheumatol, Dept Internal Med, Med Ctr, Maastricht, Netherlands

[21] Maastricht Univ, Caphri Res Inst, Maastricht, Netherlands

[22] Univ Texas MD Anderson Canc Ctr, Sect Rheumatol & Clin Immunol, Dept Gen Internal Med, Houston, TX USA

[23] Western Sydney Univ, Sydney, NSW, Australia

[24] Royal North Shore Hosp Univ Sydney, Dept Rheumatol, Sydney, Australia

[25] Queens Univ, Sch Rehabil Therapy, Kingston, ON, Canada

[26] Univ Med Berlin, Dept Internal Med 2, Schlosspark Klin,Rheumatol Res Ctr, Clin Immunol Osteol Phys Therapy & Sports Med, Berlin, Germany

[27] Univ Washington, Seattle Childrens Hosp, Dept Pediat, Div Rheumatol, Seattle, WA USA

[28] Univ Calgary, Dept Med, Calgary, AB, Canada

[29] Univ Calgary, Cumming Sch Med, Dept Med, Dept Community Hlth Sci, Calgary, AB, Canada

[30] Univ Lorraine, INSPIIRE, INSERM, Nancy, France

[31] Canterbury Kings Coll London, Canterbury, Kent, England

[32] Kings Coll London, London, England

[33] Vanshavardhana Canada Integrated Hlth, Toronto, ON, Canada

[34] Int Fdn Autoimmune & Autoinflammatory Arthrit Ai, New York, NY USA

[35] McGill Univ, Div Clin Epidemiol, Rheumatol & Resp Epidemiol & Clin Trials Unit, Montreal, PQ, Canada

[36] McGill Univ Hlth Ctr, Res Inst, Montreal, PQ, Canada

[37] Johns Hopkins Med, Div Rheumatol, Montreal, PQ, Canada

[38] Univ Alabama Birmingham, Birmingham, AL USA

[39] Univ Alabama Birmingham, Div Pediat Rheumatol, Dept Pediat, Birmingham, AL USA

[40] Suez Canal Univ, Dept Rheumatol & Rehabil, Fac Med, Ismailia, Egypt

[41] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands

[42] UCB Pharma B V Netherlands, Leiden, Netherlands

[43] Univ Sheffield, Fac Med Dent & Hlth, Sheffield, S Yorkshire, England

[44] Univ Hosp Strasbourg, Dept Rheumatol, CRMR RESO, Strasbourg, France

[45] Univ Adelaide, Adelaide Med Sch, Fac Hlth & Med Sci, Adelaide, SA, Australia

[46] Diakonhjemmet Hosp, Ctr treatment Rheumat & Musculoskeletal Dis REMED, Oslo, Norway

[47] St Clares Mercy Hosp, Newfoundland & Labrador Hlth Serv, St John, NF, Canada

[48] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA USA

[49] Int Univ Rabat UIR, Hlth Sci Res Ctr CReSS, Fac Med, Rabat, Morocco

[50] Bispebjerg & Frederiksberg Hosp, Parker Inst, Sect Biostat & Evidence Based Res, Copenhagen, Denmark

来源：

SEMINARS IN ARTHRITIS AND RHEUMATISM | 2024年 / 65卷

基金：

美国国家卫生研究院; 加拿大健康研究院;

关键词：

OMERACT; Rheumatology; Shared decision making; Core domain set; Consensus-building; Survey;

D O I：

10.1016/j.semarthrit.2024.152381

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objective: To gain consensus on the definitions and descriptions of the domains of the Outcome Measures in Rheumatology (OMERACT) core domain set for rheumatology trials evaluating shared decision making (SDM) interventions. Methods: Following the OMERACT Handbook methods, our Working Group (WG), comprised of 90 members, including 17 patient research partners (PRPs) and 73 clinicians and researchers, had six virtual meetings in addition to email exchanges to develop draft definitions and descriptions. The WG then conducted an international survey of its members to gain consensus on the definitions and descriptions. Finally, the WG members had virtual meetings and e-mail exchanges to review survey results and finalize names, definitions and descriptions of the domains. Results: WG members contributed to developing the definitions. Fifty-two members representing four continents and 13 countries completed the survey, including 15 PRPs, 33 clinicians and 37 researchers. PRPs and clinicians/ researchers agreed with all definitions and descriptions with agreements ranging from 87% to 100%. Respondents suggested wording changes to the names, definitions and descriptions to better reflect the domains. Discussions led to further simplification and clarification to address common questions/concerns about the domains. Conclusion: Our WG reached consensus on the definitions and descriptions of the domains of the core domain set for rheumatology trials of SDM interventions. This step is crucial to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set. Clinical significance: The current study provides consensus-based definitions and descriptions for the domains of the OMERACT core domain set for shared decision making interventions from patients/caregivers, clinicians and researchers. This is a crucial step to understand each domain and provides the foundation to identify instruments to measure each domain for inclusion in the Core Outcome Measurement Set for trials of SDM interventions.

引用

页数：9